**Vaxcyte Launches Public Offering of Common Stock and Pre-Funded Warrants**
Vaxcyte, Inc., a clinical-stage vaccine company based in San Carlos, California, has initiated an underwritten public offering of $500 million in common stock and pre-funded warrants. The company will be the sole seller of the shares and warrants in this offering. Additionally, underwriters have been granted a 30-day option to …